Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples